Guenther M G, Lane W S, Fischle W, Verdin E, Lazar M A, Shiekhattar R
Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine and Genetics, and The Penn Diabetes Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 USA.
Genes Dev. 2000 May 1;14(9):1048-57.
The corepressor SMRT mediates repression by thyroid hormone receptor (TR) as well as other nuclear hormone receptors and transcription factors. Here we report the isolation of a novel SMRT-containing complex from HeLa cells. This complex contains transducin beta-like protein 1 (TBL1), whose gene is mutated in human sensorineural deafness. It also contains HDAC3, a histone deacetylase not previously thought to interact with SMRT. TBL1 displays structural and functional similarities to Tup1 and Groucho corepressors, sharing their ability to interact with histone H3. In vivo, TBL1 is bridged to HDAC3 through SMRT and can potentiate repression by TR. Intriguingly, loss-of-function TRbeta mutations cause deafness in mice and humans. These results define a new TR corepressor complex with a physical link to histone structure and a potential biological link to deafness.
共抑制因子SMRT介导甲状腺激素受体(TR)以及其他核激素受体和转录因子的抑制作用。在此,我们报告从HeLa细胞中分离出一种新型的含SMRT复合物。该复合物包含转导素β样蛋白1(TBL1),其基因在人类感音神经性耳聋中发生突变。它还包含HDAC3,一种以前认为不会与SMRT相互作用的组蛋白脱乙酰基酶。TBL1与Tup1和Groucho共抑制因子在结构和功能上具有相似性,共享与组蛋白H3相互作用的能力。在体内,TBL1通过SMRT与HDAC3相连,并可增强TR的抑制作用。有趣的是,功能丧失的TRβ突变在小鼠和人类中会导致耳聋。这些结果定义了一种新的TR共抑制因子复合物,它与组蛋白结构存在物理联系,与耳聋存在潜在的生物学联系。